Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD72 (clone 4IG4I). We employs the pUC (CMV-YFP-GR-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD72
Clone
4IG4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
CMV
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.86
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.